- Home
- PIII vs TRIB Comparison
PIII vs TRIB Comparison
Compare PIII & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIII
- TRIB
- Stock Information
- Founded
- PIII 2015
- TRIB 1992
- Country
- PIII United States
- TRIB Ireland
- Employees
- PIII N/A
- TRIB N/A
- Industry
- PIII Medical/Nursing Services
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PIII Health Care
- TRIB Health Care
- Exchange
- PIII Nasdaq
- TRIB Nasdaq
- Market Cap
- PIII 30.8M
- TRIB 25.5M
- IPO Year
- PIII N/A
- TRIB N/A
- Fundamental
- Price
- PIII $0.18
- TRIB $0.57
- Analyst Decision
- PIII Hold
- TRIB
- Analyst Count
- PIII 2
- TRIB 0
- Target Price
- PIII $0.25
- TRIB N/A
- AVG Volume (30 Days)
- PIII 710.9K
- TRIB 36.7K
- Earning Date
- PIII 03-27-2025
- TRIB 05-22-2025
- Dividend Yield
- PIII N/A
- TRIB N/A
- EPS Growth
- PIII N/A
- TRIB N/A
- EPS
- PIII N/A
- TRIB N/A
- Revenue
- PIII $1,500,455,000.00
- TRIB $59,126,000.00
- Revenue This Year
- PIII $21.45
- TRIB $11.63
- Revenue Next Year
- PIII N/A
- TRIB $10.13
- P/E Ratio
- PIII N/A
- TRIB N/A
- Revenue Growth
- PIII 18.48
- TRIB N/A
- 52 Week Low
- PIII $0.15
- TRIB $0.56
- 52 Week High
- PIII $0.89
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- PIII 45.80
- TRIB 34.26
- Support Level
- PIII $0.16
- TRIB $0.63
- Resistance Level
- PIII $0.20
- TRIB $0.71
- Average True Range (ATR)
- PIII 0.02
- TRIB 0.05
- MACD
- PIII 0.00
- TRIB -0.01
- Stochastic Oscillator
- PIII 49.57
- TRIB 3.66
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.